Tue, Sep 2, 2014, 9:17 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • chrttwelve chrttwelve Jan 13, 2010 1:26 PM Flag

    If the 2010 closing low of $18.53 holds .....

    Adherents to the nearly-infallible Range Theory would be looking for at least $23 for the year's closing high.

    And if $23 is going to be the high, how far-fetched can it be to be looking for $29-$30 sometime in 2012?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • > how far-fetched can it be to be looking for $29-$30 sometime in 2012?


      what happened to your $42 prediction?

      ==================================================
      Re: It's in management's interest to keep PFE under $25 26-Sep-07 04:17 am

      The difference between a stock like PFE paying a 5.1% yield at current prices instead of 4.8% is the difference between a COMPELLING buy and just a very good buy in the eyes of many investors.

      5% for a rock-solid blue-chip secular growth stock is the holy grail - because it means that just a 5% gain from stock price appreciation would get the overall return to the magic double-digit level that most retirees want.

      With a full 5% dividend yield, a $24 stock just has to go up by a little over a point in a year's time and the 10% return is obtained.

      For this reason, you rarely see a stock like Pfizer on the list of full 5% dividend payers among S & P 500 stocks. The ONLY current 5% dividend payer among S & P stocks that isn't a financial, energy or telecom is Reynolds Tobacco, a very slow grower laden with debt, paying out 75% of its profits in dividends and having many years of legal settlements ahead of it. That isn't exactly a Pfizer, is it?

      Regarding the likelihood of Pfizer declining, time is very much on the company's side. The more time that goes by, the closer it gets to when it is absolutely in the clear at the end of 2011 - with the Lipitor expiration behind it, expected to earn $2.60 or so in 2012 and then five years of expected double-digit earnings growth given the unbelievably-low patent expiration schedule.

      Certainly a company in such a situation would at least warrant the same kind of 16 or 17 multiple that the likes of LLY, BMY and MRK have NOW - with those companies soon to suffer the loss of major drugs.

      So the closer it gets to the end of 2011, the closer Pfizer should be to having its stock in the low 40's. The stock doesn't figure to go from $25 at the end of 2010 to $42 or some such a year later - as time draws nearer, the stock should certainly advance from current levels. This is what you are missing. How can you have so little imagination as to not see this?

      chrt13
      ===============================================================

    • Also, once finally over $29, PFE should enjoy a short-term spurt as that would be something like a seven or eight-year high. The last time that Pfizer closed above $29 was in November 2004 before the adverse Celebrex test results came out.

    • As far-fetched as you are tetched in the head.

      Your betters warned you, same as since 2003.

    • >> > The question was first posed just ten hours ago

      13-Jan-10 02:08 pm <<


      He's not very good with numbers you know...

    • optionsalchemists2357 optionsalchemists2357 Jan 14, 2010 11:40 PM Flag

      > The question was first posed just ten hours ago



      13-Jan-10 02:08 pm


      Dumbass.

    • Don't you want to apologize to all those "adherents" who "invested" based upon your "range theory" founded "advice"?

    • pretty far-fetched....another polar-opposite of reality..

    • Oops, never mind.

      I see you are looking at old posts.|


      My bad.

    • Bawahahahahahahhahahahahahahahahahahahahahahahahahhahahaha

    • I see that I missed that post as well. I can tell when that happens as the missed post won't have a rating by me.

 
PFE
29.26-0.13(-0.44%)Sep 2 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.